Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

Chan Joon Kim(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Jong‐Seon Park(Korea University Medical Center), Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital), Joon‐Hyung Doh(Inje University Ilsan Paik Hospital), Jang Hyun Cho, Ki‐Bae Seung, Kwan Yong Lee(Catholic University of Korea), Yun Seok Choi(Inje University), Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital), Seung‐Ho Hur(Keimyung University Dongsan Medical Center), Yong‐Hoon Jeong(Chosun University), Byung‐Hee Hwang(The Catholic University of Korea Seoul St. Mary's Hospital), Myeong‐Ho Yoon(The Catholic University of Korea Daejeon St. Mary's Hospital), Young‐Hoon Jeong(Chung-Ang University Hospital), Ju Yeol Baek(The Catholic University of Korea Bucheon St. Mary's Hospital), Myung Ho Jeon, Byung Ryul Cho(Kangwon National University), Mahn‐Won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Hyeon Woo Yim(National Institute of Environmental Health Sciences), Eun‐Seok Shin(Ulsan University Hospital), Youngkeun Ahn(Chonnam National University Hospital), Won Bae Kim(Seoul National University), Min Chul Kim(Chonnam National University), Myung Ho Jeong(Veterans Health Service Medical Center), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Doo‐Soo Jeon(University of Ulsan), Kyung Tae Jung(St. Paul's Hospital)
The Lancet
October 1, 2021
Cited by 202


Related Papers